Journal Article

Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women

Armstrong, Drew, Cernasev, Alina, Golden, Jay, Walker, Crystal

2021

Overview

Although the incidence of new cases of human immunodeficiency virus (HIV) has decreased in the past decade, in 2018 more than 7000 women with HIV were diagnosed in the United States (US). Globally, per recent reports, 48% of the new HIV infections were among women. There is still no vaccine to prevent HIV transmission. However, pre-exposure prophylaxis (PrEP) was approved in 2012 by the Food and Drug Administration, providing a powerful tool to block HIV infection and help prevent the subsequent development of acquired immunodeficiency syndrome (AIDS). The uptake of PrEP has been slow globally and among the most vulnerable populations in the US, even though the Centers for Disease Control (CDC) recommended its use in high-risk populations, including women. Furthermore, women represent one-quarter of people living with HIV in the US; however, PrEP is underutilized in this group. Thus, it is imperative to make women’s voices heard through conducting more research, ensuring sufficient access to PrEP, and enhancing knowledge about PrEP as a viable prevention strategy for women. This article aims to promote women’s health by changing the narrative, providing key information on empowering women, and increasing the usage of PrEP.

• Publisher: MDPI AG
• Subject: Acquired immune deficiency syndrome / AIDS / Antiretroviral drugs / Condoms / Disease prevention / Disease transmission / HIV / HIV-negative / Human immunodeficiency virus / PrEP / truvada for PrEP / women / Womens health